US FDA Grants Orphan Drug Designation to iOnctura’s Autotaxin Cancer Therapy

US FDA Grants Orphan Drug Designation to iOnctura’s Autotaxin Cancer Therapy

iOnctura, a prominent clinical-stage biotechnology company dedicated to advancing revolutionary cancer therapies, has achieved a significant milestone with the recent…